Who are Moleculeralabs's investors?

Moleculeralabs's investors include Plains Ventures.

Moleculeralabs

Founded 2011 · 14 employees on LinkedIn · 1 known investors

Moleculera Biosciences is a precision medicine company that develops blood-based immune-mediated autoantibody testing panels and AI-driven diagnostic tools to identify immune dysfunction underlying chronic neuropsychiatric and cardiovascular disorders, as well as Alzheimer's disease. The company operates an integrated platform combining diagnostic panels, a biorepository with bioinformatics, and a therapeutic target identification program.

AI & Machine Learning Biotech Digital Health Medical Devices

Investors · 1

Plains VenturesOklahoma City · $250K – $1M

Competitors · 1

by search overlap

Moleculera174 shared keywordsMoleculera develops precision medicine technologies for identifying and treating immune-mediated disorders, including neuropsychiatric and cardiovascular conditions, using blood-based autoantibody testing panels, biobank data, and biomarker identification. The company serves healthcare providers and patients seeking diagnosis of treatment-resistant neuropsychiatric and autoimmune disorders.

Companies competing with Moleculeralabs for the same Google search keywords, organic and paid, via search-intersection analysis.

Frequently asked questions

What does Moleculeralabs do?: Moleculera Biosciences is a precision medicine company that develops blood-based immune-mediated autoantibody testing panels and AI-driven diagnostic tools to identify immune dysfunction underlying chronic neuropsychiatric and cardiovascular disorders, as well as Alzheimer's disease. The company operates an integrated platform combining diagnostic panels, a biorepository with bioinformatics, and a therapeutic target identification program.
Who are Moleculeralabs's investors?: Moleculeralabs's investors include Plains Ventures.